Literature DB >> 23133225

Primary hyperparathyroidism: A report of two unusual cases.

Sanoop K Zachariah1, P A Thomas.   

Abstract

Primary hyperparathyroidism (PHPT) has a variable clinical expression. Majority of the patients are asymptomatic. Symptomatic PHPT with classical skeletal, renal, abdominal and neuro-psychiatric manifestations have become exceedingly rare. Asymptomatic maternal PHPT manifesting as neonatal hypocalcaemic convulsions is another rare entity. The commonest cause of PHPT are solitary parathyroid adenomas. These benign tumors are extremely small being difficult to identify even at surgical exploration. Very large tumors known as giant adenomas are uncommon. Double parathyroid adenomas account for only a small percentage of the lesions associated with PHPT. Considerable debate exists as to whether double adenomas are a distinct entity or represent early stages of four gland hyperplasia. We report two interesting cases of PHPT with classical features, that have become rare today such as nephrolithiasis, nephrocalcinosis, and X-ray findings of bone disease, caused by unusual pathological lesions like double and giant adenomas and discuss rare presentations like neonatal convulsions.

Entities:  

Keywords:  Double adenoma; Neonatal convulsions; Primary hyperparathyroidism

Year:  2010        PMID: 23133225      PMCID: PMC3452502          DOI: 10.1007/s12262-010-0031-6

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  6 in total

1.  Double adenoma of the parathyroid gland: does the entity exist?

Authors:  Z W Baloch; V A LiVolsi
Journal:  Arch Pathol Lab Med       Date:  2001-02       Impact factor: 5.534

2.  Rare presentation of maternal primary hyperparathyroidism.

Authors:  G C Beattie; N R Ravi; M Lewis; H Williams; A W Blair; I W Campbell; G G Browning
Journal:  BMJ       Date:  2000-07-22

3.  Giant solitary parathyroid adenoma presenting with bone disease.

Authors:  T R Sai Prasad; V Bhatnagar
Journal:  Indian Pediatr       Date:  2002-11       Impact factor: 1.411

4.  Circulating levels of interleukin-6 soluble receptor predict rates of bone loss in patients with primary hyperparathyroidism.

Authors:  Inaam A Nakchbandi; Mary Ann Mitnick; Robert Lang; Caren Gundberg; Barbara Kinder; Karl Insogna
Journal:  J Clin Endocrinol Metab       Date:  2002-11       Impact factor: 5.958

5.  Color-Doppler in the imaging work-up of primary hyperparathyroidism.

Authors:  M Meola; M Barsotti; C Lenti; M Luperini; L Cavanna; G Barsotti
Journal:  J Nephrol       Date:  1999 Jul-Aug       Impact factor: 3.902

6.  A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery.

Authors:  S J Silverberg; E Shane; T P Jacobs; E Siris; J P Bilezikian
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

  6 in total
  2 in total

1.  Giant parathyroid tumours in primary hyperparathyroidism: a systematic review.

Authors:  Ho Kiu Grace Wong; Kate Shipman; Kimberley Allan; Andrew Ghabbour; Farzad Borumandi
Journal:  Langenbecks Arch Surg       Date:  2022-01-18       Impact factor: 3.445

Review 2.  Primary hyperparathyroidism-related giant parathyroid adenoma (Review).

Authors:  Adina Ghemigian; Alexandra Ioana Trandafir; Eugenia Petrova; Mara Carsote; Ana Valea; Alexandru Filipescu; Ana-Maria Oproiu; Florica Sandru
Journal:  Exp Ther Med       Date:  2021-11-26       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.